# Call for a consensual definition of dyslipidemia in coronary angiography trials

**Authors:** Aurélien Clerc, Mario Togni, Stephane Cook

PMC · DOI: 10.3389/fcvm.2025.1506149 · Frontiers in Cardiovascular Medicine · 2025-02-05

## TL;DR

This paper highlights the lack of a consistent definition for dyslipidemia in coronary angiography studies and proposes a standardized definition to improve accuracy in cardiovascular risk assessments.

## Contribution

The paper proposes a consensual definition of dyslipidemia using the 'lipid triad' components for both primary and secondary prevention.

## Key findings

- Only 20% of 258 studies provided a definition of dyslipidemia, with 39 different definitions identified.
- The proposed definition includes specific thresholds for LDL, HDL, and triglycerides based on age and sex.
- Standardizing dyslipidemia definitions can reduce misinterpretations in cardiovascular risk assessments.

## Abstract

Dyslipidemia is extensively analyzed in clinical trials investigating its role as a risk factor for coronary artery disease (CAD). However, its definition varies vastly among studies, leading to different attributions to the variable dyslipidemia. The objectives of this study are to verify the hypothesis of a lack of a consensual definition of dyslipidemia in coronary angiography studies and to propose a consensual definition of dyslipidemia, considering the influence of each serum lipid parameter on mortality. A systematic search of coronary angiography studies focusing on dyslipidemia was conducted. We listed definitions and their references in the 258 articles the research found. Out of the 258 articles retrieved in the search, 52 studies (20%) provided a definition of dyslipidemia, and 20 (8%) mentioned the source. We identified 39 different definitions. To mitigate misinterpretations of cardiovascular risk factors, we propose the use of the “lipid triad” components to define dyslipidemia: LDL-cholesterol >3.0 mmol/L for primary prevention and >2.6 mmol/L or >1.4 mmol/L for secondary prevention in patients over/under 75 years old, respectively; or HDL-cholesterol <1.3 mmol/L (women) and <1.0 mmol/L (men); or triglycerides >1.7 mmol/L.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010), dyslipidemia (MONDO:0002525)

## Full-text entities

- **Diseases:** Dyslipidemia (MESH:D050171), CAD (MESH:D003324)
- **Chemicals:** triglycerides (MESH:D014280), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11836034/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC11836034/full.md

---
Source: https://tomesphere.com/paper/PMC11836034